Literature DB >> 10963881

Oocyte attrition.

K Reynaud1, M A Driancourt.   

Abstract

During oogenesis, germ cell numbers sharply decrease when meiosis is initiated. There is solid evidence (DNA ladders, in situ detection) that this loss is through apoptosis. Oocyte apoptosis appears to hit mitotic primordial germ cells (PGC), pachytene oocytes and early primordial follicles. The control of oocyte apoptosis is not fully understood, although survival factors (LIF, kit ligand and FGF), as well as death inducing factors (fas ligand, TGFbeta), have been identified. Fas ligand binding on oocytic fas may result in caspase 8 activation. Two pathways inducing oocyte apoptosis may then be operating. In the first one, activated caspase 8 will induce activation of executioner caspases. In the second one, activated caspase 8 will trigger the cleavage of the bcl(2) family member Bid, which will act on mitochondria, resulting in cytochrome c release, caspase 9 activation and finally, activation of all executioner caspases. As a consequence of caspase activation, alterations in the cell nucleus (DNAse activation, PARP fragmentation), in the cell cytoskeleton (lamin) and cell metabolism will occur, producing cell death. During folliculogenesis, germ cell loss, owing to oocyte apoptosis, has been postulated within primordial and preantral follicles. Its regulatory mechanisms may be even more complex than those operating in foetal oocytes since additional control factors include EGF/TGFalpha and bcl(2) (survival) and activin (death inducer). In contrast, oocytes from antral follicles appear to be very unsensitive to death inducing stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963881     DOI: 10.1016/s0303-7207(99)00246-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  18 in total

Review 1.  Cell death in development: shaping the embryo.

Authors:  Carlos Penaloza; Lin Lin; Richard A Lockshin; Zahra Zakeri
Journal:  Histochem Cell Biol       Date:  2006-07-01       Impact factor: 4.304

Review 2.  Biochemical alterations in the oocyte in support of early embryonic development.

Authors:  Jacinta H Martin; Elizabeth G Bromfield; R John Aitken; Brett Nixon
Journal:  Cell Mol Life Sci       Date:  2016-09-07       Impact factor: 9.261

3.  JAK/STAT signaling prevents excessive apoptosis to ensure maintenance of the interfollicular stalk critical for Drosophila oogenesis.

Authors:  Antoine Borensztejn; Alexandra Mascaro; Kristi A Wharton
Journal:  Dev Biol       Date:  2018-03-21       Impact factor: 3.582

Review 4.  Cell death in animal development.

Authors:  Piya Ghose; Shai Shaham
Journal:  Development       Date:  2020-07-24       Impact factor: 6.868

5.  Lhx8 ablation leads to massive autophagy of mouse oocytes associated with DNA damage.

Authors:  Laura D'Ignazio; Marc Michel; Melissa Beyer; Kassimier Thompson; Antonino Forabosco; David Schlessinger; Emanuele Pelosi
Journal:  Biol Reprod       Date:  2018-04-01       Impact factor: 4.285

6.  Accelerated apoptosis in the Timp-3-deficient mammary gland.

Authors:  J E Fata; K J Leco; E B Voura; H Y Yu; P Waterhouse; G Murphy; R A Moorehead; R Khokha
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

7.  Testosterone induces activation of porcine primordial follicles in vitro.

Authors:  Manjula P S Magamage; Mai Zengyo; Mohammad Moniruzzaman; Takashi Miyano
Journal:  Reprod Med Biol       Date:  2010-10-14

8.  Maternal diabetes increases apoptosis in mice oocytes, not 2-cell embryos.

Authors:  Shaoda Lin; Kun Lin; Weiping Li; Xiaolin Zhou; Tianhua Huang
Journal:  Endocrine       Date:  2010-04-21       Impact factor: 3.633

9.  Prognostic implication of apoptosis in human luteinized granulosa cells during IVF-ET.

Authors:  Chang Suk Suh; Byung Chul Jee; Young Min Choi; Jung Gu Kim; Jin Yong Lee; Shin Yong Moon; Seok Hyun Kim
Journal:  J Assist Reprod Genet       Date:  2002-05       Impact factor: 3.412

Review 10.  Maintaining the reproductive potential of cancer patients during cancer treatment.

Authors:  Djana Harp; Indrajit Chowdhury; Minerva Garcia-Barrio; Crystal Welch; Roland Matthews; Winston Thompson
Journal:  Front Biosci (Schol Ed)       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.